Stacy Price
Hoofd Techniek/Wetenschap/O&O bij INVIVYD, INC.
Vermogen: - $ op 31-05-2024
Actieve functies van Stacy Price
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| INVIVYD, INC. | Hoofd Techniek/Wetenschap/O&O | 01-03-2023 | - |
Loopbaan van Stacy Price
Eerdere bekende functies van Stacy Price
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| AKOUOS | Hoofd Techniek/Wetenschap/O&O | 01-11-2021 | - |
| ALAUNOS THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | - | - |
Opleiding van Stacy Price
| Tufts University | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
Operationeel
| Chief Tech/Sci/R&D Officer | 3 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ALAUNOS THERAPEUTICS, INC. | Health Technology |
| INVIVYD, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Akouos, Inc.
 Akouos, Inc. BiotechnologyHealth Technology Akouos, Inc. is a precision genetic medicine company, which engages in the development of precision genetic medicines to restore and preserve hearing in genetically-defined patient populations. The firm's lead product candidate, AK-OTOF, is a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. It develops targeted adeno-associated viral vector based gene therapies for sensorineural hearing loss, which results from dysfunction or damage to sensory cells and nerve fibers of the inner ear. The company was founded by Emmanuel J. Simons, William F. Sewell, Richard H. Smith, Luk H. Vandenberghe, and Michael J. McKenna on March 7, 2016 and is headquartered in Boston, MA. | Health Technology |
- Beurs
- Insiders
- Stacy Price
- Ervaring
